JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, X.-L.
Right arrow Articles by Barone, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, X.-L.
Right arrow Articles by Barone, F. C.

Vol. 298, Issue 3, 879-885, September 2001

Oxidative Inactivation of Nitric Oxide and Endothelial Dysfunction in Stroke-Prone Spontaneous Hypertensive Rats

Xin-Liang Ma, Feng Gao, Allen H. Nelson, Bernard L. Lopez, Theodore A. Christopher, Tian-Li Yue and Frank C. Barone

Department of Surgery, Division of Emergency Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania (X.-L.M., B.L.L., T.A.C.); Department of Physiology, Fourth Military Medical University, Xian, People's Republic of China (F.G.); and Department of Cardiovascular Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania (A.H.N., T.-L.Y., F.C.B.)

This study tested the hypothesis that increased nitric oxide (NO) inactivation and concurrent peroxynitrite formation is responsible for endothelial dysfunction in the spontaneously hypertensive stroke-prone rat (SHRSP). In SHRSP, the aortic vasorelaxation to acetylcholine (ACh) was decreased (p < 0.05), but NO production was unchanged. Nitrotyrosine staining, a footprint of peroxynitrite (ONOO-) formation, was detected. Exposure of SHRSP to a high-salt, high-fat diet (SFD) further exacerbated hypertension and accelerated end-organ disease. A severe endothelial dysfunction [maximal ACh relaxation: 49.8 ± 2.1 versus 94.5 ± 1.8% in Wistar-Kyoto rats (WKY), p < 0.01], increased basal NO production (482 ± 17 versus 356 ± 21 nM, p < 0.01), decreased ACh-stimulated NO production (57 ± 6 versus 112 ± 6 nM, p < 0.01), extensive inducible NO synthase and nitrotyrosine staining, elevated nitrotyrosine content (21-fold increase over WKY), and a high percentage of cells with DNA damage were observed in the aortic tissues from these animals. Treatment of SHRSP on SFD with carvedilol restored ACh-induced vasorelaxation and NO production, inhibited nitrotyrosine formation, reduced vascular cell DNA damage, and reduced end-organ injury. These data demonstrate that endothelial dysfunction was caused by increased NO inactivation alone (SHRSP) or in combination with decreased NO production from endothelial NO synthase (SHRSP on SFD). Antioxidant treatment with carvedilol exerted significant vascular protective effects, attenuated end-organ damage, and decreased mortality under these conditions.

0022-3565/01/2983-0879$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
X.-Y. Jiao, E. Gao, Y. Yuan, Y. Wang, W. B. Lau, W. Koch, X.-L. Ma, and L. Tao
INO-4885 [5,10,15,20-Tetra[N-(benzyl-4'-carboxylate)-2-pyridinium]-21H,23H-porphine Iron(III) Chloride], a Peroxynitrite Decomposition Catalyst, Protects the Heart against Reperfusion Injury in Mice
J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 777 - 784.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
B. Rentzsch, M. Todiras, R. Iliescu, E. Popova, L. A. Campos, M. L. Oliveira, O. C. Baltatu, R. A. Santos, and M. Bader
Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
Hypertension, November 1, 2008; 52(5): 967 - 973.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. Tao, E. Gao, X. Jiao, Y. Yuan, S. Li, T. A. Christopher, B. L. Lopez, W. Koch, L. Chan, B. J. Goldstein, et al.
Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative Stress
Circulation, March 20, 2007; 115(11): 1408 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Hu, X. Jiao, E. Gao, W. J. Koch, S. Sharifi-Azad, Z. Grunwald, X. L. Ma, and J.-Z. Sun
Chronic beta-Adrenergic Receptor Stimulation Induces Cardiac Apoptosis and Aggravates Myocardial Ischemia/Reperfusion Injury by Provoking Inducible Nitric-Oxide Synthase-Mediated Nitrative Stress
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 469 - 475.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. Liang, E. Gao, L. Tao, H. Liu, Y. Qu, T. A Christopher, B. L Lopez, and X. L Ma
Critical timing of L-arginine treatment in post-ischemic myocardial apoptosis--role of NOS isoforms
Cardiovasc Res, June 1, 2004; 62(3): 568 - 577.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Wu, M. H. Noyan Ashraf, M. Facci, R. Wang, P. G. Paterson, A. Ferrie, and B. H. J. Juurlink
Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system
PNAS, May 4, 2004; 101(18): 7094 - 7099.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
H.-R. Liu, L. Tao, E. Gao, B. L Lopez, T. A Christopher, R. N Willette, E. H Ohlstein, T.-L. Yue, and X.-L. Ma
Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion
Cardiovasc Res, April 1, 2004; 62(1): 135 - 144.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Ju, D. J. Behm, S. Nerurkar, M. E. Eybye, R. E. Haimbach, A. R. Olzinski, S. A. Douglas, and R. N. Willette
p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 1. p38 MAPK-Dependent Endothelial Dysfunction and Hypertension
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 932 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
X. Gu, A. B. El-Remessy, S. E. Brooks, M. Al-Shabrawey, N.-T. Tsai, and R. B. Caldwell
Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite
Am J Physiol Cell Physiol, September 1, 2003; 285(3): C546 - C554.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. Kalinowski, L. W. Dobrucki, M. Szczepanska-Konkel, M. Jankowski, L. Martyniec, S. Angielski, and T. Malinski
Third-Generation {beta}-Blockers Stimulate Nitric Oxide Release From Endothelial Cells Through ATP Efflux: A Novel Mechanism for Antihypertensive Action
Circulation, June 3, 2003; 107(21): 2747 - 2752.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.